Compare Badger Meter Inc (BMI) vs GeneDx Holdings Corp (WGS) Price & Performance

Badger Meter (BMI) trades at $134.77, down 1.22% amid bearish technical signals and mixed quarterly results. The stock shows strong profitability with 14.27% net margins and 18.48% ROE, though valuation appears elevated with a P/E of 31.78. Recent news highlights multiple class-action lawsuits filed against the company, creating investor uncertainty despite insider buying activity and institutional position increases.

BMI faces near-term headwinds from legal challenges and earnings misses, but maintains solid fundamentals and analyst consensus target of $155.20 suggests 15% upside potential. The key risk remains resolution of securities litigation, while the company's strong cash flow generation and market position in water technology provide long-term stability.

GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.

Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.